CD19 and precursor B-cell acute lymphoblastic leukemia: However, Orlando and co-workers suggested that alternative splicing changes in B-ALL patients are present in diagnostic samples already (albeit at low frequencies) and may not contribute meaningfully to CD19 epitope loss5.